InvestorsHub Logo
Followers 480
Posts 60642
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Monday, 11/27/2017 10:08:29 AM

Monday, November 27, 2017 10:08:29 AM

Post# of 460322
There is no reason to believe that BIIB has rejected 2-73. None of the other drugs has the potential for remyelination of neurons that 2-73 has shown.

The most likely explination - Missling wants more money than Biogen wants to part with at this time.



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News